The exchange-traded fund tracking the NEAR Protocol token has received approval to begin trading, according to multiple reports.
NYSE Arca has approved a Bitwise exchange-traded fund built around the NEAR Protocol token, clearing the way for the product to list and trade, according to CoinGape and BlockchainReporter. The approval represents a milestone for NEAR, a layer-1 blockchain network, as it moves closer to having a regulated investment vehicle available to mainstream investors.
Following the news, the price of the NEAR token climbed sharply. AMBCrypto reported a 26% surge in the token’s value, tying the move directly to the ETF development. Price reactions of this size are not uncommon when a token gains a pathway to traditional exchange-traded products, since such approvals can widen the pool of investors able to gain exposure without holding the asset directly.
Bitwise has built a track record of pursuing crypto-linked fund products across multiple digital assets. The firm has previously sought and secured listings tied to other major tokens, positioning itself among the more active issuers in the space. A NEAR-focused ETF would extend that lineup into a network known for its focus on scalability and developer accessibility.
An ETF listing on NYSE Arca means the fund can trade on one of the most established U.S. exchange platforms. This matters because it places the product within existing brokerage and retirement account infrastructure. Investors who might otherwise avoid direct crypto custody could gain indirect exposure through standard investment accounts.
The approval also fits into a broader pattern of expanding institutional access to crypto assets through regulated wrappers. Bitcoin and Ethereum exchange-traded products opened the door for similar structures tied to other tokens. Approval of a NEAR-linked fund suggests regulators and exchanges are continuing to evaluate additional networks for similar treatment.
Details on the fund’s exact launch date, ticker, and structure were not included in the available reporting. It remains to be seen how quickly trading will begin following the NYSE Arca approval, and how demand will compare to earlier crypto-linked ETF debuts.
Market watchers will likely track trading volumes and price behavior around the launch closely. Early ETF debuts for other tokens have sometimes produced volatile price swings as markets adjust to new capital flows and revised expectations for institutional demand.
Sources disagree on this story
This article was published before the reports below were compared. The reporting above stands; what follows is where the published accounts do not agree.
Outlets agree NYSE Arca approved the Bitwise NEAR ETF listing, but CryptoBriefing says the SEC also confirmed the registration's effectiveness while BlockchainReporter and AMBCrypto say the SEC has not yet acted on the security itself.
What all sources agree on
- Bitwise NEAR ETF received approval to list and trade on NYSE Arca under the ticker NRR.
- The fund carries a 0.75% annual management fee.
- The Trust intends to stake 100% of its NEAR holdings, with staking expenses equal to 33% of additional NEAR generated (leaving roughly 67% retained by the Trust).
- Bitwise Investment Manager is expected to buy an initial seed basket of 20,000 shares for $500,000.
- NEAR's price rallied sharply following the news, trading near $5.
Where the reports disagree
1Whether the SEC has confirmed effectiveness of the registration statement
NYSE Arca approved the listing application, and the SEC confirmed the effectiveness of the trust’s registration statement via Form 8-A on the same date, setting up a potential launch around September 29.
The listing approval is an exchange-level step; the SEC has not approved or disapproved the securities themselves.
However, the SEC has yet to approve or disapprove its effectiveness.
What would settle it: The SEC's public filing record for the Bitwise NEAR Trust, including the Form 8-A status and any related SEC order or notice of effectiveness.
What to make of it
Treat the NYSE Arca listing approval, ticker, fee, and staking structure as established since all outlets agree; do not assume the SEC has separately confirmed the registration's effectiveness until the SEC's own filing record is checked.
Market Impact
The approval could increase visibility for NEAR Protocol within traditional finance circles, particularly among investors who prefer exchange-based products over direct token custody. A listed ETF may also improve liquidity and provide a new benchmark price reference tied to regulated markets.
The sharp price move reported around the news illustrates how sensitive crypto asset prices remain to regulatory and listing developments. Sustained price effects will depend on actual fund inflows once trading begins, rather than on the approval announcement alone.
The NYSE Arca approval marks a significant step for NEAR Protocol's integration into mainstream financial markets, though further details on the fund's launch and performance will determine its lasting impact.
Frequently Asked Questions
What has NYSE Arca approved?
NYSE Arca has approved a Bitwise exchange-traded fund tied to the NEAR Protocol token for listing and trading, according to reports from CoinGape and BlockchainReporter.
How did the NEAR token price react to the news?
The NEAR token price rose sharply after the approval, with AMBCrypto reporting a surge of 26% in its report on the development.
Is Bitwise's NEAR ETF already trading?
The reports indicate the fund has been approved to list and trade on NYSE Arca, but specific launch timing was not detailed in the available reporting.
Why does an ETF listing matter for a crypto token like NEAR?
A listed ETF gives investors indirect exposure to NEAR through standard brokerage accounts, without requiring direct custody of the token, potentially widening its investor base.
Read More
All News
October 22, 2026
OCC Stablecoin Rule: Outlets Disagree on NPRM Date
October 22, 2026
